Challenging Perceptions.
Transforming Innovations.
Changing Lives.

Challenging Perceptions.

Transforming Innovations.

Changing Lives.

We back the world’s most ambitious sci-entrepreneurs to turn bold science into healthcare ventures at the frontier of Bio-AI.  

We help you go from lab bench to first-in-human faster — engineering companies that are scientifically rigorous, commercially viable, investment-ready, and clinically meaningful.

[apply now]

Panacea Stars is a globally leading venture builder for Bio-AI and healthtech.

Healthcare is hard—slow, capital-heavy, and unforgiving. Too many breakthroughs stall in the lab.

We believe the future of medicine will be engineered with pace and precision—at the intersection of biology and intelligence.

Whether you're exploring a concept, searching for a co-founder, advancing IP, or gearing up to scale—our mission is to help you building it.

[Read Our Manifesto]

Truly Invested.
From First Insight to First-in-Human.

We turn bold science into investable companies through precision-guided venture building—with a full-stack designed for the complexities of healthcare.

We don’t advise from the sidelines. We build, de-risk, and scale—shoulder to shoulder.

AI-Native Infrastructure & Insight

Support and strategic access to leading AI platforms and experts.

Clinically & Commercially Relevant

Access pharma, CROs, regulators, payers, hospitals, and patient orgs.

Hands-On Venture Building

Work with experts and your own EIR to refine IP and execution.

Global Ecosystem

1000+ alumni. 200+ mentors. Investors, clinicians, operators.

Co-Founder Matching & Talent Access

Partner with academic, clinical, and commercial talent.

Themed Venture Programmes

From idea to investment—tailored to venture maturity.

Panacea Capital.  
Real Capital for Real Companies.

We invest through Panacea Capital—our dedicated Bio-AI venture investment platform led by VCs, Entrepreneurs and operators who’ve built and backed category leaders.

Pre-seed and seed capital

Milestone-linked investment

Follow-on support through Series A and beyond

[Visit Panacea Capital]